1. Background {#sec83071}
=============

Heart size is an important and helpful diagnostic parameter in chest X-ray (CXR); however, presence or absence of cardiomegaly in CXR depends on the interpreter's judgment ([@A18242R1]). Even in one case, interpretations of different physicians could vary ([@A18242R1], [@A18242R2]). Naturally, some hypertrophic changes, without dilatation, occur in heart muscles by aging, which is often detectable by CXR ([@A18242R3]-[@A18242R5]). It is noteworthy that cardiomegaly is developed by different diseases, including valvular heart diseases, IHD, and cardiomyopathy as well as pericardial diseases.

Also, we should remember that increased CTR, especially in the middle-aged and elderly patients is correlated with IHD and increased rate of morbidity and mortality. Enlarged heart size is an independent predictor of death, and an increased CTR in CXR, irrespective of its etiology, is associated with poor prognosis in middle-aged patients. This issue is indicative of great importance and necessity of early diagnosis, especially in older patients ([@A18242R6]-[@A18242R11]).

In other words, according to Frishman et al. CXR screening paves the way for timely therapeutic interventions ([@A18242R6]). In another study, it was revealed that CTR is as important as relative heart volume in the prediction of the mortality induced by IHD. In addition, only PA view of CXR is needed to determine CTR ([@A18242R8]).

However, in the field of pediatric cardiology, Davidson's study showed that CTR has no correlation with echocardiographic findings and also Spiewak's study revealed that CTR in patients with repaired Tetralogy of Fallot can show atrial rather than ventricular dilatation, which could lead to false determination of ventricular size ([@A18242R12], [@A18242R13]).

Nowadays, various methods, with different efficiencies are applied for chest imaging and determination of the heart size. In this regard, echocardiography as an advanced method in the diagnosis of cardiac diseases has made CXR less important. Echocardiography is highly versatile, but operator dependent technique. Two-dimensional echocardiography gives direct imaging information about the anatomy and physiology of the heart, which identifying particular anatomical planes within the heart relies on the operator ([@A18242R14], [@A18242R15]). It is notable that two-dimensional echocardiography has to be performed by a cardiologist, whose access is quite difficult compared to a general practitioner.

Also, echocardiography is more expensive than CXR, and is not always successful as expected, especially in old and obese ones or in patients with increased lung volumes ([@A18242R8], [@A18242R16]). Above all, more than 75% of physicians in Iran are general practitioners and less than 25% are specialists (of course only a few of them are cardiologist). Furthermore, availability of medical instruments could play a significant role, especially at first line of diagnosis ([@A18242R11]). Having considered the aforementioned issues, we designed this study to compare radiological findings of CXR with echocardiography in determination of the heart size and show the value of standard PA CXR as a cost-effective and applicable approach in diagnosis of the heart size. However, determination of the heart size in radiography could be affected by different factors, including the shape and the size of thorax, patient's position at imaging, air in the lungs and respiratory diseases. Sometimes heart enlargement, especially in its mild or average status is overlooked. Accurate differentiation of the normal heart size from its abnormal size could be difficult. Therefore, different diagnoses among physicians are inevitable ([@A18242R1]).

2. Objectives {#sec83072}
=============

A good quality posterior-anterior (PA) chest radiograph is an important indicator of the cardiac size. Nowadays, CXR has given its place to more advanced approaches such as two-dimensional echocardiography. However, CXR is still more accessible and feasible for most of the physicians. This study was designed to compare the findings of CXR and echocardiography in determination of the heart size.

3. Patients and Methods {#sec83073}
=======================

This cross-sectional study was carried out in one specialized state-run hospital in Tehran, Iran, from June 2006 to July 2007. The cases were patients who had undergone echocardiography and PA CXR maximum within two days. In fact, patients were first supposed to undergo both echocardiography and CXR in one day, but due to unstable condition of some patients in cardiology ward, we finally decided to study patients who had undergone both procedures in two consecutive days. Additionally, patients who took portable CXR were excluded from the study, because it is not standard in determination of the heart size. The sample size was calculated with an expected power of 90%.

A total of 225 patients, admitted to the cardiology ward, were selected by random sampling method, and finally 197 of them met the inclusion criteria. Patient's heart size was determined by 2-D echocardiography and PA CXR. We used CTR as the most common method of describing the heart size ([@A18242R17]).

The standard PA CXR (taken by analog calibrated Toshiba system with this criteria: Beam limiting device, model TF-6TL-6, input 1-phase 50/60Hz AC12V, max input power 100VA, max tube voltage 150KV, filtration 1.2 mm) was taken on deep inspiration which was interpreted only by one radiologist and CTR was recorded as shown in [Figure 1](#fig16085){ref-type="fig"}, which is less than 50 % in normal condition ([@A18242R6], [@A18242R11], [@A18242R17]).

![Determination of the Heart Size on the Standard PA CXR](ircmj-17-01-18242-g001){#fig16085}

One cardiologist carried out the echocardiography (GE, Vingmed4, with mode 2-D, parasternal and 4 chambers). RVEDD and LVEDD were used to measure the echocardiographic size of the heart. They were determined by 2-D echocardiography and in normal condition are less than 25 mm and 55 mm, respectively ([@A18242R18]-[@A18242R22]). In this study, adequate physical activity for adults has been defined according to WHO recommendations ([@A18242R23]).

Ethics Committee of Islamic Azad University, Tehran Medical Sciences Branch approved this study with the ethical number 3802. Although, there was not any intervention in this study, we considered "the protection code of human subjects in medical research" of Iran\'s Ministry of Health and Medical Education. Because we used the patients' records, all the information was kept confidential ([@A18242R24]).

SPSS version 16 was used to analyze the extracted data, and chi-square test to assess qualitative variables such as heart enlargement in echocardiography and radiography, and the mean of RVEDD and LVEDD in the non-cardiomegal and the cardiomegal cases (according to the CXR findings of a radiologist) were compared with Mann-Whitney U test. The level of significance was considered less than 0.05.

4. Results {#sec83074}
==========

Ninety-nine patients (50.3%) were male and 98 (49.7%) were female. The mean age was 57.47 ± 10.75 years, ranged from 34 to 86 years. One hundred and fifty patients were non-smoker and 47 were smoker. The median of pack-year in smokers was 18 p/y ranged from 1 to 60 p/y. Forty-eight patients (24.4%) had acceptable physical activity according to WHO recommendations, whereas 149 (75.6%) did not. The history of IHD and hypertension were seen in 52.3% and 38.6% of the patients, respectively.

According to CXR and echocardiography, 49 (24.9%) and 100 (50.8%) patients had cardiomegaly, respectively. All variables were compared between cardiomegal and non-cardiomegal patients based on CXR and echocardiography ([Tables 1](#tbl21126){ref-type="table"} and [2](#tbl21127){ref-type="table"}).

Overall, there was a significant difference between the heart size determined by echocardiography and CXR (P = 0.003). Additionally, our study revealed a statistically significant difference between CTR in IHD patients and CTR in non-IHD patients (P = 0.02).

Moreover, sensitivity and specificity of CXR in diagnosis of cardiomegaly were 34% and 84.5%, respectively, which could be helpful in screening cardiomegaly. In fact, when PA view of CXR indicates absence of heart enlargement, to a great extent, the same result can be seen in echocardiography ([Table 3](#tbl21128){ref-type="table"}).

###### Comparison of the Variables Between Cardiomegal Patients According to CXR and Echocardiography ^[a](#fn18862){ref-type="table-fn"}^

                                                                            The Patients With Cardiomegaly According to Chest X-Ray (n = 49)   The Patients With Cardiomegaly According to Echocardiography (n = 100)
  ------------------------------------------------------------------------- ------------------------------------------------------------------ ------------------------------------------------------------------------
  **Age, y [^b^](#fn18946){ref-type="table-fn"}**                           62.41 (43-82)                                                      59.00 (34-85)
  **Gender** ^**[a](#fn18862){ref-type="table-fn"}**^                                                                                          
  Male                                                                      12 (24)                                                            52 (52)
  Female                                                                    37 (76)                                                            48 (48)
  **RVEDD, mm**                                                             25 (18-40) and IQR = 7 b                                           27.32 (18-40) [^b^](#fn18946){ref-type="table-fn"}
  **LVEDD, mm** ^**[c](#fn18863){ref-type="table-fn"}**^                    54(36-70) and IQR = 13                                             56 (35-70) and IQR = 7
  **History of IHD** ^**[a](#fn18862){ref-type="table-fn"}**^               33 (67)                                                            55 (55)
  **History of HTN** ^**[a](#fn18862){ref-type="table-fn"}**^               29 (59.2)                                                          41 (41)
  **Smoking** ^**[a](#fn18862){ref-type="table-fn"}**^                      6 (12)                                                             20 (20)
  **Suitable physical activity** ^**[a](#fn18862){ref-type="table-fn"}**^   10 (20)                                                            23 (23)

^a^Data are presented as No. (%).

^b^Mean ( range).

^c^ Median, range, and interquartile range (IQR).

###### Comparison of the Variables Between the Patients With Normal Heart According to CXR and Echocardiography ^[a](#fn18864){ref-type="table-fn"}^

                                                                            Patients With Normal Heart According to Chest X-Ray (n = 148)     Patients With Normal Heart According to Echocardiography (n = 97)
  ------------------------------------------------------------------------- ----------------------------------------------------------------- -------------------------------------------------------------------
  **Age, y**                                                                55.00 (34-86) and IQR = 15 ^[b](#fn18865){ref-type="table-fn"}^   55.90 (34-86) ^[c](#fn18947){ref-type="table-fn"}^
  **Gender** ^**[a](#fn18864){ref-type="table-fn"}**^                                                                                         
  Male                                                                      87 (59)                                                           47 (48)
  Female                                                                    61 (41)                                                           50 (52)
  **RVEDD, mm** ^**[b](#fn18865){ref-type="table-fn"}**^                    24 (15-37) and IQR = 5                                            23 (15-25) and IQR = 3
  **LVEDD, mm** ^**[b](#fn18865){ref-type="table-fn"}**^                    49 (34-63) and IQR = 11                                           45 (34-55) and IQR = 8
  **History of IHD** ^**[a](#fn18864){ref-type="table-fn"}**^               70 (47)                                                           48 (49)
  **History of HTN** ^**[a](#fn18864){ref-type="table-fn"}**^               47 (32)                                                           35 (36)
  **Smoking ^[d](#fn18866){ref-type="table-fn"}^**                          41 \[16(1-60)\] and IQR = 21.5                                    27 \[15(1-60)\] and IQR = 20
  **Suitable physical activity** ^**[a](#fn18864){ref-type="table-fn"}**^   38(26%)                                                           25 (26%)

^a^ Data are presented as No. (%).

^b^ Median, range and interquartile range (IQR).

^c^ Mean (range).

^d^ The number of smokers \[median , range and interquartile range(IQR) of P/Y in smokers\].

###### Comparison of the Heart Size Determined in CXR and Echocardiography ^[a](#fn18867){ref-type="table-fn"}^

                                              Normal Heart Size in CXR   Cardiomegaly in CXR
  ------------------------------------------- -------------------------- ---------------------
  **Normal heart size in echocardiography**   41.6                       7.6
  **Cardiomegaly in echocardiography**        33.5                       17.3

^a^ Data are presented as %.

The median of LVEDD and RVEDD were 50 mm (34-70 mm) and 24 mm (15-40 mm), respectively. Additionally, the means were compared in normal (CTR \< 50%) and enlarged (CTR ≥ 50%) heart size in CXR with Mann-Whitney U-test, which demonstrated a statistically significant difference between them (P value \< 0.05, [Table 4](#tbl21129){ref-type="table"}).

###### The Mean Size of RVEDD and LVEDD Determined by Echocardiography in Normal and Enlarged Heart Size in CXR ^[a](#fn18868){ref-type="table-fn"}^

                                     Mean of RVEDD in Echocardiography   Mean of LVEDD in Echocardiography
  ---------------------------------- ----------------------------------- -----------------------------------
  **CTR \< 50% in CXR**              24.17 ± 3.92                        48.91 ± 6.37
  **CTR ≥ 50% in CXR**               26.57 ± 4.74                        51.59 ± 8.31
  **P** **value (Mann-Whitney U)**   0.002                               0.023

^a^ Data are presented as Mean ± SD.

5. Discussion {#sec83075}
=============

Cardiomegaly is an independent prognostic factor for mortality, and increased CTR, which (regardless of its etiology) is associated with poor prognosis in older patients. However, our study showed a significant difference between CTR in IHD and non-IHD patients (P = 0.02).

It should be noted that cardiomegaly found in CXR correlates with 1.84 times increase in mortality. Also LV hypertrophy determined by echocardiography is associated with 1.5 to 4 times increase in mortality, which is indicative of great importance and necessity of early diagnosis, especially in old or middle-aged patients ([@A18242R6], [@A18242R8], [@A18242R16]). Cardiomegaly could result in mortality due to some mechanisms such as higher oxygen need by larger ventricular mass, fatal ventricular arrhythmias, and endothelial dysfunction ([@A18242R25]-[@A18242R27]). LV size as an independent factor can be an indicator of cardiovascular diseases, which could be estimated by CTR ([@A18242R10], [@A18242R16], [@A18242R28]).

Jung et al. showed that CTR in the detection of pathologic End Diastolic Volume Index and Ejection Fraction had 77.3% and 57.4% sensitivity, 79.3% and 80.8% specificity, and 78.9% and 72.5% accuracy, respectively. They concluded that CTR in standard CXR can play an important role in screening and follow-up of patients with cardiac disease ([@A18242R29]). Furthermore, in Nakamori's study, CTR was considered as the most effective measurement in CXR to detect cardiomegaly, which has the minimum false positive in comparison with transverse and longitudinal diameter of the heart and lungs ([@A18242R1]). Also, Perez et al. designed a study on patients with Chagas disease and concluded that abnormal radiological findings in PA CXR in comparison with echocardiography had 50% sensitivity and 80.5% specificity ([@A18242R30]). In another study, although single-dimension echocardiography was shown to be able to differentiate left ventricular hypertrophy from dilatation, it did not show lateral or inferior enlargement of the heart. In other words, single-dimension echocardiography does not accurately determine size of the right ventricle ([@A18242R31]).

On the contrary, in another study the clinical value of cardiac volume determined by CXR, as a parameter for left ventricular (LV) systolic function, was considered low and dependent on the cause of heart enlargement, and accuracy of CXR in diagnosis of cardiomegaly was seen to be significantly lower than that of echocardiography. Also Clark et al. demonstrated that echocardiography and radionuclide ventriculography can depict the degree of LV dysfunction much better than the CXR ([@A18242R32]). In our study, there was a significant difference in terms of the heart size in echocardiography and CXR (P = 0.003). However, this issue was predictable from the beginning steps of the study, and we did not mean to underestimate the value of echocardiography, but one of the objectives of this study was to clarify that this diagnostic tool should be used at a proper stage of approaching the patient (not for example screening).

Thus, this study is designed to clarify to what extent CXR can be reliable in the detection of cardiomegaly. The result indicates that CXR does not have high degree of sensitivity (34%), despite its specificity (84.5%), which in Jung study were 48.8% and 93.6% respectively. These findings are quite compatible with our findings. This slight difference between these two studies seems to be due to the study method. In Jung study, besides PA view, lateral view was also taken, but in our study the PA view was merely taken to lower the risk of X-ray exposure and also to be able to compare this study with other studies ([@A18242R29]).

In other words, when PA view of CXR indicates absence of heart enlargement, to a great extent, the same result can be seen in echocardiography, which is suggestive of the remarkable role of CXR in screening.

Finally, CXR as a diagnostic procedure is not as strong and accurate as echocardiography, but its accessibility and high degree of specificity in diagnosis of cardiomegaly would be very beneficial for the majority of medical practitioners, especially in screening process and patient detection.

Moreover, if CTR has increased in comparison with the previous CXR, it could be more important than merely knowing the CTR without comparison with other CXRs. Consequently, it seems that a research project is on demand in which patients undergo both echocardiography and CXR at a regular and constant follow up, so that these two procedures could be compared in the long run and their relationship with prognosis of cardiovascular patients be evaluated.

We are very grateful to the head nurse of cardiology ward of Javaheri Hospital, Mrs Leila Omidvar, for her sincere cooperation in data collection.

**Authors' Contributions:**Dr Ali Biharas Monfared gathered most of the data, analyzed them, and wrote the first draft, which was his dissertation. Dr Shahnaz Agha Farajollah revised the manuscript and advised the other authors to write the manuscript. Dr Fahimeh Sabour revised and gathered the data. Dr Roya Farzanegan revised the manuscript. Dr Shahram Taghdisi technically revised the manuscript as a cardiologist.
